Functional annotation of native enhancers with a Cas9-histone demethylase fusion.
about
Next generation sequencing technology and genomewide data analysis: Perspectives for retinal researchBrain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the futureTherapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targetingMaking sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genomeBeyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogationApplications of CRISPR-Cas systems in neuroscienceHow specific is CRISPR/Cas9 really?Epigenetic marks: regulators of livestock phenotypes and conceivable sources of missing variation in livestock improvement programsApplications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology ResearchEnabling functional genomics with genome engineeringStrategies for precision modulation of gene expression by epigenome editing: an overviewGenomic Views of Transcriptional Enhancers: Essential Determinants of Cellular Identity and Activity-Dependent Responses in the CNSChromatin Dynamics in Lineage Commitment and Cellular ReprogrammingThe CRISPR revolution and its impact on cancer researchThe epigenome: the next substrate for engineeringCRISPR-Mediated Epigenome EditingEpigenetic Editing: On the Verge of Reprogramming Gene Expression at WillLigand-binding domains of nuclear receptors facilitate tight control of split CRISPR activityStabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.Genome engineering of stem cell organoids for disease modeling.Complex transcriptional modulation with orthogonal and inducible dCas9 regulators.Genetic and epigenetic control of gene expression by CRISPR-Cas systems.Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems.Applications of CRISPR technologies in research and beyond.Systematic Analysis of Known and Candidate Lysine Demethylases in the Regulation of Myoblast Differentiation.LSD1: biologic roles and therapeutic targeting.Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and DiseaseGenome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activatorsMultiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNAGenome-scale CRISPR pooled screens.Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells.CORALINA: a universal method for the generation of gRNA libraries for CRISPR-based screeningFunctional interrogation of non-coding DNA through CRISPR genome editing.CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elementsCRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.Cas9 Variants Expand the Target Repertoire in Caenorhabditis elegansTowards a compendium of essential genes - From model organisms to synthetic lethality in cancer cells.
P2860
Q26746206-8791312C-BDB4-4261-ABEA-3544A67C538EQ26753206-1EBF6B9B-F763-4465-9658-0470DE976711Q26768602-AB1398C0-29E8-46F3-A44D-A40E14E62BA0Q26771497-4A5670B5-EA4A-41A9-9FCB-93151ED41397Q26775746-A6BDB538-0137-4E84-8BEA-C2D14F73386BQ26776515-66DD1F74-6446-42E3-86A6-4CECAE8D537EQ26777801-511F3CA7-11F5-47DD-BF61-6B2517AEDE15Q26781132-DBC4F9FD-EB85-4221-9EDA-7DD7A3A5BDDAQ26781399-EBF12147-6A05-4EF5-AB9D-3FCBAE3DBEF6Q26782747-174977B3-5D20-40EC-9832-2FEF38A81DE8Q26782876-BE0B3729-9271-48DA-9063-B848D22DBC9DQ26782959-92936D1E-0834-46DC-B1CA-F87B905C5F1AQ26801740-A30B2139-62F0-48EB-8DED-90A8871F64F9Q26824997-947C517A-F3EA-4899-845C-CC17B59C44DCQ28068278-8E664E22-9FAD-41C6-A279-E1C20FE9847BQ28075872-199692D0-5984-48E3-8310-DAC2D29AFE5DQ28080188-B46FE380-6583-42F3-AA59-2A0AD7F3816DQ28831343-B842208D-9E96-4AA1-95D3-E041E50F1182Q30356570-3D7F5A91-AB9D-4E19-8DC2-04F62403056EQ33628093-F9CAC7C3-70A8-44F5-AB14-397FB8E84D0FQ33704483-A3181752-EC27-493E-B5A4-66192BE70F73Q33777855-A4F13B0A-567E-4033-A7BB-A9BF5A0C3745Q34504751-D00821F0-789B-4547-A32B-B9F3C232BF6AQ34536517-423FEF6F-A374-4DD3-9372-F9F704B6F7A0Q34539796-1092FF6B-80A4-4BA8-92F6-FEABB0FC0024Q34542432-7C9B7393-9287-4836-BBC3-C389AD09ABACQ34678086-40BC147C-F7DE-4BC2-B338-462153329F29Q35747943-6155BC5A-7159-471C-9C2F-61ECC5098B9EQ35876055-3D3851E7-D2CC-4B73-B486-19B38582FA85Q35920105-A12454B7-DD61-4A33-9509-DD7319B45337Q35999041-6A235305-5698-4A74-9A81-F0243E143299Q36040827-5487EB5C-A9DE-4FA0-BB3B-2F3908E0A652Q36178493-578AFF47-52F6-4322-BB8A-5140E3F4401EQ36191861-DA4B3146-8571-432D-BDFE-7A072420E573Q36306820-009818B1-6538-4BF1-8176-598DD067E69EQ36331722-5FD5FA09-0B6A-420B-9E90-8B014406526EQ36338669-6D6FC421-9821-4CB8-970E-4EA6D67FF600Q36675292-95A3B368-37D7-4196-B2E9-54417F5DA65EQ36677241-9ECCCD28-43F5-4198-AAEB-936006645E0CQ36762503-14019214-53F7-49A9-A259-B8791D734803
P2860
Functional annotation of native enhancers with a Cas9-histone demethylase fusion.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Functional annotation of native enhancers with a Cas9-histone demethylase fusion.
@ast
Functional annotation of native enhancers with a Cas9-histone demethylase fusion.
@en
type
label
Functional annotation of native enhancers with a Cas9-histone demethylase fusion.
@ast
Functional annotation of native enhancers with a Cas9-histone demethylase fusion.
@en
prefLabel
Functional annotation of native enhancers with a Cas9-histone demethylase fusion.
@ast
Functional annotation of native enhancers with a Cas9-histone demethylase fusion.
@en
P2093
P2860
P356
P1433
P1476
Functional annotation of native enhancers with a Cas9-histone demethylase fusion
@en
P2093
Barbara Tabak
Hannah Pham
Manuel Garber
René Maehr
Ryan M Genga
P2860
P2888
P304
P356
10.1038/NMETH.3325
P577
2015-03-16T00:00:00Z